Connor, M. J., Shah, T. T., Sukumar, J., Basak, D., Fiorentino, F., Heath, C., . . . Ahmed, H. U. (2025). IP26-35 NOVEL CYTOREDUCTIVE PROSTATE ABLATIVE THERAPIES IN DE NOVO METASTATIC PROSTATE CANCER: LESSONS LEARNT FROM A PHASE II INTERNAL PILOT RANDOMISED STUDY (IP2-ATLANTA). Journal of Urology, 213, . https://doi.org/10.1097/01.ju.0001110200.18879.65.35
Παραπομπή σε μορφή Chicago (17η εκδ.)Connor, Martin J., et al. "IP26-35 NOVEL CYTOREDUCTIVE PROSTATE ABLATIVE THERAPIES IN DE NOVO METASTATIC PROSTATE CANCER: LESSONS LEARNT FROM A PHASE II INTERNAL PILOT RANDOMISED STUDY (IP2-ATLANTA)." Journal of Urology 213 (2025). https://doi.org/10.1097/01.ju.0001110200.18879.65.35.
Παραπομπή σε μορφή MLA (9th εκδ.)Connor, Martin J., et al. "IP26-35 NOVEL CYTOREDUCTIVE PROSTATE ABLATIVE THERAPIES IN DE NOVO METASTATIC PROSTATE CANCER: LESSONS LEARNT FROM A PHASE II INTERNAL PILOT RANDOMISED STUDY (IP2-ATLANTA)." Journal of Urology, vol. 213, 2025, https://doi.org/10.1097/01.ju.0001110200.18879.65.35.